Section Arrow
Quote
CAMP.NASDAQ
- Camp4 Therapeutics Corp
Quotes are at least 15-min delayed:2026/04/08 21:55 EDT
Regular Hours
Last
 4.58
-0.07 (-1.51%)
Day High 
4.77 
Prev. Close
4.65 
1-M High
7.75 
Volume 
39.08K 
Bid
4.3
Ask
6.25
Day Low
4.56 
Open
4.75 
1-M Low
3.89 
Market Cap 
241.25M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.46 
20-SMA 4.91 
50-SMA 4.49 
52-W High 7.75 
52-W Low 1.305 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.65/--
Enterprise Value
242.94M
Balance Sheet
Book Value Per Share
0.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.50M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.1831+0.0201+12.33%-- 
VRAXVirax Biolabs Group Limited0.15+0.01+7.14%-- 
ELABPmgc Holdings Inc4.5+1.05+30.43%0PE
CUECue Biopharma0.2738+0.0856+45.48%-- 
GERNGeron Corp1.71-0.03-1.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development ofa new class of RNA-based therapeutics to treat a broad range of genetic diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.